Gatifloxacin/Prednisolone Acetate

加替沙星/醋酸泼尼松龙

Report date: 2022/04/08 14:35:55

Base Information

Drug NameGatifloxacin/Prednisolone Acetate

Drug Alias Nameprednisolone acetate/gatifloxacin醋酸泼尼松龙/加替沙星gatifloxacin + prednisolone acetategatifloxacin/prednisolone acetateZypred

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibioticsSmall molecules > Steroids

Mechanisms of ActionGlucocorticoid receptor agonistsTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors

TargetsGlucocorticoid receptorTopoisomerase IVBacterial DNA gyrase

Therapy Area/IndicationsInflammationEye Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAllergan Plc

China Registration ClassN/A

Active CompaniesAllergan Plc

Inactive CompaniesN/A

Active IndicationsInflammationEye Infections

Inactive IndicationsN/A

ATC CodeR01AD52S03CA02